期刊文献+

抑制肺鳞癌细胞FANCM和USP1基因对顺铂的增敏效应 被引量:1

Effect of sensitization to cisplatin by inhibiting FANCM and USP1 in lung squamous carcinoma cells
下载PDF
导出
摘要 目的:研究抑制FANCM和USP1基因后,人肺鳞癌SK-MES-1细胞株FA/BRCA通路激活状态以及对顺铂敏感性的变化。方法:用脂质体转染试剂将FANCM-siRNA和USP1-siRNA分别和共转染于SK-MES-1细胞株,采用蛋白质印迹法测定转染后FANCM和USP1蛋白表达,并检测转染前后经DDP处理后细胞FANCD2蛋白单泛素化水平。免疫荧光染色检测胞核内FANCD2核聚小体表达。CCK-8法测定转染前后细胞生存率的变化;Annexin V/PI流式细胞术测定转染前后细胞凋亡率。结果:转染FANCM-siRNA和USP1-siRNA后,SK-MES-1细胞中FANCM和USP1蛋白表达均较转染前明显降低。转染FANCM-siRNA后经顺铂诱导的FANCD2单泛素化水平和核聚小体表达明显下调;转染USP1-siRNA后,顺铂诱导的FANCD2单泛素化水平和核聚小体形成明显增加;转染USP1-siRNA后细胞生存率和细胞凋亡率高于转染FANCM-siRNA,同时共转染USP1-siRNA+FANCM-siRNA后细胞对顺铂的致敏效应与转染USP1-siRNA相似。结论:沉默FANCM和USP1基因后,通过阻断FA/BRCA通路,抑制其DNA修复功能,导致SKMES-1细胞对顺铂的敏感性增高,其中沉默USP1基因的增敏效应更为明显。 Objective : To explore the effect of inhibition of FA/BRCA pathway upstream genes FANCM and USP1 on the sensitivity of lung squamous cell carcinoma SK-MES-1 to cisplatin. Methods: FANCM- siRNA and USPl-siRNA were transfected into SK-MES-1 cells using RNA interference (RNAi) technique according to manufacture's instructions. The transfection efficacy was verified by testing the FANCM and USP1 protein expression using Western blotting, which was also used to detect the levels of FANCD2 monoubiquitination. CCK-8 technique was conducted to detect the survival of SK-MES-1 cells treated with cisplatin pre-transfection and post-transfection of USPI-siRNA and FANCM-siRNA. Flow cytometry using Annexin V/PI methods was performed to measure cell apoptosis. Immunofluorescence assay was done to de- termine the expression of FANCD2 nuclear loci. Results : FANCM and USP1 proteins expressions were ob- viously decreased after transfection of FANCM-siRNA and USP1-siRNA compared with before transfection. FANCM gene silence resulted in down-regulation of the FANCD2 monoubiquitination and nuclear loci ex- pression. The USP1 silence increased the FANCD2 monoubiquitination levels and nuclear foci expression. Meanwhile, the silencing of the two genes significantly suppressed the cell survival and promoted cell apop- tosis induced by cisplatin. The sensitizing effect to cisplatin in silencing USP1 was more obvious than in si- lencing FANCM. Conclusion : Depletion of FANCM and USP1 gene by RNAi can enhance the sensitivity of lung squamous carcinoma cells to cisplatin through depression of the FA/BRCA pathway DNA repair func- tion.
出处 《江苏大学学报(医学版)》 CAS 2016年第2期147-153,共7页 Journal of Jiangsu University:Medicine Edition
关键词 肺鳞癌细胞 FA/BRCA通路 顺铂 FANCM USP1 SIRNA lung squamous cell carcinoma FA/BRCA pathway cisplatin FANCM USP1 siRNA
  • 相关文献

参考文献19

  • 1姜贺果,戴春华,李坚,陈永昌,蓝婷,伍敏.siRNA沉默FANCD2基因增加肺癌A549/DDP细胞对顺铂化疗的敏感性[J].江苏大学学报(医学版),2014,24(3):201-206. 被引量:3
  • 2Knipscheer P,Rschle M,Smogorzewska A,et al.The Fanconi anemia pathway promotes replication-dependent DNA interstrand cross-link repair[J].Science,2009,326(5960):1698-1701.
  • 3Kee Y,D'Andrea AD.Expanded roles of the Fanconi anemia pathway in preserving genomic stability[J].Genes Dev,2010,24(16):1680-1694.
  • 4Vaz F,Hanenberg H,Schuster B,et al.Mutation of the RAD51C gene in a Fanconi anemia-like disorder[J].Nat Genet,2010,42(5):406-409.
  • 5Stoepker C,Hain K,Schuster B,et al.SLX4,a coordinator of structure-specific endonucleases,is mutated in a new Fanconi anemia subtype[J].Nat Genet,2011,43(2):138-141.
  • 6Wang W.Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins[J].Nat Rev Genet,2007,8(10):735-748.
  • 7Taniguchi T,D'Andrea AD.Molecular pathogenesis of Fanconi anemia:recent progress[J].Blood,2006,107(11):4223-4233.
  • 8Medhurst AL,Laghmani el H,Steltenpool J,et al.Evidence for subcomplexes in the Fanconi anemia pathway[J].Blood,2006,108(6):2072-2080.
  • 9Ciccia A,Ling C,Coulthard R,et al.Identification of FAAP24,a Fanconi anemia core complex protein that interacts with FANCM[J].Mol Cell,2007,25(3):331-343.
  • 10Gari K,Décaillet C,Delannoy M,et al.Remodeling of DNA replication structures by the branch point translocase FANCM[J].Proc Natl Acad Sci U S A,2008,105(42):16107-16112.

二级参考文献25

  • 1Cho BC,Kim JH,Soo RA,et al.The role of monoclonalantibody in combination with first line chemotherapy in A-sian patients with advanced non-small cell lung cancer[J].Yonsei Med J,2010,51(1):1-8.
  • 2Yang CT,Hung JY,Lai CL,et al.Gemcitabine as first-line therapy for advanced or metastatis non-small cell lungcancer patients in southern Taiwan[J].Kaohsiung J MedSci,2010,26(1):1-7.
  • 3Demedts IK,Vernaelen KY,van Meerbeeck JP.Treat-ment of extensive-stage small cell lung carcinoma:currentstatus and future prospects[J].Eur Respir J,2010,35(1):202-215.
  • 4Knipscheer P,Raschle M,Smogorzewka A,et al.TheFanconi anemia pathway promotes replication-dependentDNA interstrand cross-link repair[J].Science,2009,326(5960):1698-1701.
  • 5Taniguchi T,D'Andrea AD.Molecular pathogenesis of Fanconi anemia:recent progress[J].Blood,2006,107(11):4223-4233.
  • 6Bagby GC,Alter BP.Fanconi anemia[J].Semin Hema-tol,2006,43(3):147-156.
  • 7Alter BP,Greene MH,Velazquez I,et al.Cancer in Fan-coni anemia[J].Blood,2003,101(5):2072.
  • 8Wang W.Emergence of a DNA-damage response networkconsisting of Fanconi anemia and BRCA proteins[J].NatRev Genet,2007,8(10):735-748.
  • 9Wu Y,Brosh RM Jr.FANCJ helicase operated in theFanconi Anemia DNA repair pathway and the response toreplicational stress[J].Curr Mol Med,2009,9(4):470-482.
  • 10Fei P,Yin J,Wang W.New advances in the DNA dam-age response network of Fanconi anemia and BRCA Pro-teins[J].Cell Cycle,2005,4(1):80-86.

共引文献5

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部